- This event has passed.
Investor Spotlight: Deerfield
November 4, 2020 @ 9:00 am - 10:00 am
Let’s get more solutions to patients. The Johnson & Johnson Innovation – JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC’s, Angels and other investment entities.
Dave Greenwald from Deerfield will present an overview of the fund, it’s investment strategy, primary areas of interest, and investment case studies.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment and philanthropy—all toward the end goal of cures for disease, improved quality of life and reduced cost of care. As of June 2020, the firm manages nearly $10 billion in assets.
Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Having many years of operational expertise, Deerfielders are highly engaged and adept at navigating the complex crosscurrents ever-present in the healthcare and financial industries.
Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.